跳转至内容
Merck

P-078

Supelco

R-(-)-Phenylephrine hydrochloride solution

1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®

登录查看公司和协议定价

选择尺寸

1 ML
$148.00

$148.00


请联系客服了解存货情况

获取大包装报价

选择尺寸

变更视图
1 ML
$148.00

About This Item

经验公式(希尔记法):
C9H14ClNO2
CAS号:
分子量:
203.67
EC 号:
UNSPSC代码:
41116107
NACRES:
NA.24

$148.00


请联系客服了解存货情况

获取大包装报价

等级

certified reference material

质量水平

表单

liquid

特点

Snap-N-Spike®/Snap-N-Shoot®

包装

ampule of 1 mL

制造商/商品名称

Cerilliant®

浓度

1.0 mg/mL in methanol (as free base)

技术

gas chromatography (GC): suitable
liquid chromatography (LC): suitable

应用

forensics and toxicology

包装形式

single component solution

储存温度

−20°C

SMILES字符串

Cl.CNC[C@H](O)c1cccc(O)c1

InChI

1S/C9H13NO2.ClH/c1-10-6-9(12)7-3-2-4-8(11)5-7;/h2-5,9-12H,6H2,1H3;1H/t9-;/m0./s1

InChI key

OCYSGIYOVXAGKQ-FVGYRXGTSA-N

基因信息

一般描述

Phenylephrine, marketed as Neo-Synephrine®, is the most common over-the-counter (OTC) decongestant in the US. Over the last few years, it has been marketed as a substitute for pseudoephedrine with tighter US government regulation of pseudoephedrine from the Combat Methamphetamine Epidemic Act of 2005.

法律信息

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany
Neo-Synephrine is a registered trademark of Bayer Healthcare LLC
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany

相关产品

产品编号
说明
价格

警示用语:

Danger

危险分类

Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1

靶器官

Eyes,Central nervous system

储存分类代码

3 - Flammable liquids

WGK

WGK 2

闪点(°F)

49.5 °F - closed cup

闪点(°C)

9.7 °C - closed cup


历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助,请联系 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Doreen Schmidl et al.
Investigative ophthalmology & visual science, 54(3), 1964-1970 (2013-02-27)
We determined whether administration of a nitric oxide synthase (NOS) inhibitor alters optic nerve head blood flow (ONHBF) regulation during isometric exercise in healthy subjects. Our study was done in a randomized, placebo-controlled, double-masked, three-way crossover design. A total of
Nai-jing Li et al.
Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih, 28(1), 1-6 (2013-03-27)
To investigate the effect of phenylephrine (an α-adrenergic agonist) on alveolar fluid clearance (AFC) in ventilator-induced lung injury and the possible mechanism involved. A total of 170 male Wistar rats were randomly allocated into 17 groups (n=10) using random number
S Kauffmann et al.
Annales francaises d'anesthesie et de reanimation, 32(2), 112-114 (2013-02-05)
Adverse systemic reactions such as cardiovascular effects may occur following topical ocular application of phenylephrine. We report the case of a 49-year-old woman who, following topical application of phenylephrine eyedrops, experienced hypertension with electrocardiographic modifications and a rise in cardiac
[Eye drops in anesthesia: real drugs, real adverse events].
J-M Devys et al.
Annales francaises d'anesthesie et de reanimation, 32(2), 82-83 (2013-03-12)
J Bautista-Ortega et al.
Poultry science, 92(4), 1062-1072 (2013-03-09)
The effects of supplemental l-arginine (Arg), vitamin E (VE), and vitamin C (VC) on vascular reactivity to phenylephrine (PE) were examined in clinically healthy hypoxemic male broiler chickens. One-day-old chicks were housed in wire cages and randomly allocated to 1

Questions

Reviews

No rating value

Active Filters

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持